Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
0.4030
-0.0340 (-7.78%)
At close: Mar 31, 2025, 4:00 PM
0.4051
+0.0020 (0.51%)
Pre-market: Apr 1, 2025, 5:34 AM EDT
Ekso Bionics Holdings Revenue
In the year 2024, Ekso Bionics Holdings had annual revenue of $17.93M, down -1.94%. Ekso Bionics Holdings had revenue of $5.09M in the quarter ending December 31, 2024, with 5.01% growth.
Revenue (ttm)
$17.93M
Revenue Growth
-1.94%
P/S Ratio
0.45
Revenue / Employee
$271,591
Employees
66
Market Cap
10.00M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17.93M | -354.00K | -1.94% |
Dec 31, 2023 | 18.28M | 5.37M | 41.57% |
Dec 31, 2022 | 12.91M | 1.67M | 14.81% |
Dec 31, 2021 | 11.25M | 2.36M | 26.62% |
Dec 31, 2020 | 8.88M | -5.04M | -36.18% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
EKSO News
- 4 weeks ago - Ekso Bionics Holdings, Inc. (EKSO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 – Conference Call to Follow - GlobeNewsWire
- 7 weeks ago - NSM Named Exclusive Distributor of Ekso Indego® Personal Within the CRT Industry - GlobeNewsWire
- 4 months ago - Ekso Bionics to Showcase Its Device Technology in ‘AI for Good' Webinar on Tuesday, November 19 - GlobeNewsWire
- 4 months ago - Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference - GlobeNewsWire
- 5 months ago - Ekso Bionics Holdings, Inc. (EKSO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Ekso Bionics Announces Third Quarter 2024 Financial Results - GlobeNewsWire